Insulet Corporation to Report First Quarter 2008 Financial Results on Tuesday, May 13, 2008

BEDFORD, Mass., April 23 /PRNewswire-FirstCall/ -- Insulet Corporation , the leader in wearable insulin pump technology with its OmniPod(R) Insulin Management System, announced plans to release its financial results for the first quarter 2008 on Tuesday, May 13, 2008 after the close of the financial markets.

Insulet will also host a conference call at 5:00 p.m. Eastern Time on Tuesday, May 13, 2008 to discuss its first quarter 2008 financial results. During the conference call, material information concerning the Company, its operations, strategies and prospects may be discussed.

To listen to the conference call, please dial 866-277-1182 for domestic callers and 617597-5359 for international callers. The passcode is 40048264. A replay of the conference call will be available two hours after the start of the call through June 13, 2008 by dialing 888-286-8010 (domestic) and 617-801-6888 (international), passcode 37248432. An online archive of the conference call will also be available by accessing the Investor Information section of the company's website at http://investors.insulet.com.

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.

CONTACT: Stephanie Marks for Insulet Corporation, +1-877-763-3471,
ir@insulet.com

Web site: http://investors.insulet.com/